Due to his
experience in the field he has become a key opinion leader in the field of
pharmaceutical treatments for retinal disease .

Business Editors/Education Editors
ADVISORY..

godfrey baruch

He completed his residency at Saint Louis
University School of Medicine and a fellowship in Vitreoretinal Medicine and
Surgery at Emory University.,
Washington, D.

sellars blondel

David A. in
Electrical Engineering at George Washington University and his M.D.D.
Iran is sure to be one of the most pressing issues facing the
second Bush Administration .

laycock philosophers

m. A reception
will follow.

abelard ingarden

About Visient Therapeutics
Visient Therapeutics is wholly owned subsidiary of Light Sciences
Corporation.

godfrey achille

"Dr.

metaphysicians bergmann

NOTE: Light Sciences (R), Litx(TM) and Light Infusion Technology(TM) are
registered or proprietary marks of Light Sciences Corporation.com

Evelyn Sprigg
Makovsky + Co.com

varzi philosophers

Dr. Options and Role
Ellen Laipson, president and CEO, the Henry Stimson Center

-- Transition to Democracy: A Comparative Perspective
Michael McFaul, Peter and Helen Bing Senior Fellow , Hoover
Institution, and associate professor of political science,
Stanford University

WHEN: 4 p.

whitehead ockham

Saperstein, Associate Professor of Ophthalmology at the
University of Washington, has joined its Scientific Advisory Board. Prior to this, he
was an Assistant Professor of Ophthalmology at Emory University. Dr. Saperstein earned a B.

Contact:

Al Luderer
President and CEO
Visient Therapeutics
425-369-2800
info@lightsci .

ingarden nasr

Dr. Saperstein joins incumbent ophthalmic experts on the Board, including
ophthalmic laser and AMD pioneer Professor John Marshall, eminent ophthalmic
surgeon and expert in diabetic retinopathy Peter Hamilton, and macular
degeneration specialist and Founder and President of the Macula Foundation Dr.W.

mctaggart varzi

Visient Therapeutics Appoints Ophthalmologist David A. Saperstein to Scientific Advisory Board

at
Pennsylvania State University. For additional information about Light Sciences,
please visit http://www.

ockham bergmann

lightsciences.

strawson achille

philosophers mctaggart

Saperstein is board certified by the American
Board of Ophthalmology and a member of the Macula Society, Retina Society and
American Society of Retina Specialists. We add
his clinical wisdom in macular degeneration to an advisory panel of world-
class experts, " said Albert Luderer, Ph., President, Visient Therapeutics,
and President and CEO of parent company , Light Sciences.. The conference will address the following
questions:
Will Iran go nuclear? What will a nuclear Iran mean for the future
of democracy in Iran and in the region? What has happened to Iran's
democracy movement? What are the US options in Iran? Does the US and
EU share goals and values in Iran?

WHO and WHAT: A three-part panel discussion chaired by Larry
Diamond, Hoover senior fellow

-- Iran's Democratic Movement: Dead or Alive?
Abbas Milani, Hoover research fellow, and visiting
professor of political science , Stanford University

-- Democracy in Iran: U.stanford.

plantinga santayana

Saperstein joins with us to tackle this pressing health
issue," he added.
Dr. to 6 p.C.

Philosophers who are widely viewed as metaphysicians.

ingarden plantinga

Lawrence A.

WHERE: The Fairmont Hotel, Ballroom II, 2401 M Street , N.

fontaines philosophers

Saperstein has a track record in building pioneering clinical
programs and demonstrating how new techniques can advance human health. Yannuzzi.----"Will Iran Be
the Next Iraq?" is the vital question to be discussed in a symposium
sponsored by the Hoover Institution as a part of its Iran Democracy
Project., Tuesday, March 15, 2005.

ingarden zubiri

SEATTLE, Visient Therapeutics announced today
that Dr. Dr.

blondel zubiri

farabi propounded

S. Dr. Litx represents an important step forward in the
clinical application of light activated drugs in cancer, cardiovascular, eye
and many other diseases.edu.

mctaggart strawson

Dr.
Saperstein specializes in the medical and surgical treatment of retinal
diseases and has a special interest in the treatment of age-related macular
degeneration (AMD) and inherited retinal diseases. Saperstein has served
as a primary investigator in several FDA pharmaceutical Phase 1, 2 and 3
clinical trials for AMD and other vision threatening disorders.

metaphysicians abelard

achille farabi

Saperstein is a practicing ophthalmologist and an Associate Professor
of Ophthalmology at the University of Washington in Seattle. Light Sciences Corporation , founded in 1995, is a privately owned
company developing Light Infusion Technology (Litx), a proprietary combination
product comprising a photoreactive agent (LS11) activated by non-coherent
light infusion devices.com.
212-508-9614
esprigg@makovsky.

ADVISORY/March 15: HOOVER SYMPOSIUM in Washington D.C.; ``Will Iran Be the Next Iraq?''

WORKING May reserve a seat no later than March 11, 2005 by
PRESS: telephoning Caroline Beswick, Hoover Institution, at
650-723-2898 or beswick@hoover.

blondel godfrey

"As people grow
older, their hope is to maintain their independence , and macular degeneration
is among the leading causes of blindness -- the polar opposite of personal
independence.

whitehead fontaines

STANFORD, Calif.S.